Synthetic cannabinoids: the hidden side of Spice drugs

被引:24
作者
Pintori, Nicholas [1 ]
Loi, Barbara [3 ]
Mereu, Maddalena [2 ]
机构
[1] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy
[2] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Largo Meneghetti 2, I-35131 Padua, Italy
[3] Univ Hertfordshire, Dept Pharm Postgrad Med & Pharmacol, Psychopharmacol Drug Misuse & Novel Psychoact Sub, Hatfield, Herts, England
来源
BEHAVIOURAL PHARMACOLOGY | 2017年 / 28卷 / 06期
关键词
addiction; novel psychoactive substances; spice drugs; synthetic cannabinoids; INTRACRANIAL SELF-STIMULATION; NUCLEUS-ACCUMBENS SHELL; DOPAMINE TRANSMISSION; IN-VIVO; DESIGNER DRUGS; JWH-073; ABUSE; RESPONSIVENESS; INTOXICATION; WIN-55,212-2;
D O I
10.1097/FBP.0000000000000323
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Spice drugs are herbal mixtures sprayed with synthetic cannabinoids designed to mimic the psychoactive ingredient in marijuana [(9)-tetrahydrocannabinol ((9)-THC)] and synthesized by introducing modifications to the chemical structure of parental compounds aiming to circumvent legal regulations. Synthetic cannabinoid use/abuse can be devastating as toxicological effects and adverse reactions cannot be entirely predicted and may vary with the dose, route of administration, individual vulnerability and concomitant intake with other drugs. The absence of validated testing procedures in the clinical field makes difficult the adoption of a therapeutic approach effective in coping with the synthetic cannabinoid phenomenon, posing a significant challenge for prevention, treatment and public health in general. The aim of this review is to gain insights into the epidemiological, pharmacological and toxicological properties of synthetic cannabinoids, aiming to provide a reliable background needed for the management of synthetic cannabinoid-related adverse effects. Consumers, competent authorities and medical care professionals should be aware of the risks associated with synthetic cannabinoid use. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:409 / 419
页数:11
相关论文
共 69 条
[41]   Synthetic cannabinoid drug use as a cause or contributory cause of death [J].
Labay, Laura M. ;
Caruso, James L. ;
Gilson, Thomas P. ;
Phipps, Rebecca Jufer ;
Knight, Laura D. ;
Lemos, Nikolas P. ;
McIntyre, Iain M. ;
Stoppacher, Robert ;
Tormos, Lee Marie ;
Wiens, Andrea L. ;
Williams, Erica ;
Logan, Barry K. .
FORENSIC SCIENCE INTERNATIONAL, 2016, 260 :31-39
[42]   Marijuana effects on human forgetting functions [J].
Lane, SD ;
Cherek, DR ;
Lieving, LM ;
Tcheremissine, OV .
JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR, 2005, 83 (01) :67-83
[43]   Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration [J].
Lecca, Daniele ;
Cacciapaglia, Fabio ;
Valentini, Valentina ;
Di Chiara, Gaetano .
PSYCHOPHARMACOLOGY, 2006, 188 (01) :63-74
[44]   Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling [J].
Liechti, Matthias E. .
SWISS MEDICAL WEEKLY, 2015, 145
[45]   Synthetic cannabinoid withdrawal: A new demand on detoxification services [J].
Macfarlane, Vicki ;
Christie, Grant .
DRUG AND ALCOHOL REVIEW, 2015, 34 (02) :147-153
[46]   FAILURE OF DELTA(9)-TETRAHYDROCANNABINOL AND CP-55,940 TO MAINTAIN INTRAVENOUS SELF-ADMINISTRATION UNDER A FIXED-INTERVAL SCHEDULE IN RHESUS-MONKEYS [J].
MANSBACH, RS ;
NICHOLSON, KL ;
MARTIN, BR ;
BALSTER, RL .
BEHAVIOURAL PHARMACOLOGY, 1994, 5 (02) :219-225
[47]   In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: Inhalation versus intraperitoneal injection [J].
Marshell, R. ;
Kearney-Ramos, T. ;
Brents, L. K. ;
Hyatt, W. S. ;
Tai, S. ;
Prather, P. L. ;
Fantegrossi, W. E. .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2014, 124 :40-47
[48]   Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice [J].
Martellotta, MC ;
Cossu, G ;
Fattore, L ;
Gessa, GL ;
Fratta, W .
NEUROSCIENCE, 1998, 85 (02) :327-330
[49]   Neuroimaging in cannabis use: a systematic review of the literature [J].
Martin-Santos, R. ;
Fagundo, A. B. ;
Crippa, J. A. ;
Atakan, Z. ;
Bhattacharyya, S. ;
Allen, P. ;
Fusar-Poli, P. ;
Borgwardt, S. ;
Seal, M. ;
Busatto, G. F. ;
McGuire, P. .
PSYCHOLOGICAL MEDICINE, 2010, 40 (03) :383-398
[50]   Chronic WIN55,212-2 elicits sustained and conditioned increases in intracranial self-stimulation thresholds in the rat [J].
Mavrikaki, Maria ;
Markaki, Eirini ;
Nomikos, George G. ;
Panagis, George .
BEHAVIOURAL BRAIN RESEARCH, 2010, 209 (01) :114-118